Product Name |
Recombinant Human Biglycan (BGN) Protein |
Product Overview |
This recombinant human Biglycan (BGN) protein includes amino acids 38-368aa of the target gene is expressed in E.coli.The protein is supplied in lyophilized form and formulated in phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5% trehaloseprior to lyophilization. |
Target Uniprot Id |
P21810 |
Recommended Name |
Biglycan |
Gene Name |
BGN |
Synonyms |
Biglycan preproprotein, DSPG1, PG-S1, PGI, SLRR1A |
Species |
Human |
Predicted Molecular Mass |
39.5 kDa |
Expression System |
E.coli |
Expression Range |
38-368aa |
Tag |
N-6His |
Purity |
>95% |
Formulation |
Lyophilized |
Buffer |
Phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5%Trehalose |
Storage Condition |
1. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. 2. Avoid repeated freeze-thaw cycles. 3. Store working aliquots at 4°C for up to one week. 4. In general, protein in liquid form is stable for up to 6 months at -20°C/-80°C. Protein in lyophilized powder form is stable for up to 12 months at -20°C/-80°C. |
Reconstitution Instruction |
Briefly centrifuged the vial prior to opening to bring the contents to the bottom. Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. It is recommended to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. The default final concentration of glycerol is 50%. |
Applications |
Positive Control; Immunogen; SDS-PAGE; WB |
Research Area |
Signal Transduction |
Target Function |
May be involved in collagen fiber assembly. |
Subcellular Location |
Secreted, extracellular space, extracellular matrix. |
Protein Family |
Small leucine-rich proteoglycan (SLRP) family, SLRP class I subfamily |
Associated Diseases |
Meester-Loeys syndrome (MRLS); Spondyloepimetaphyseal dysplasia, X-linked (SEMDX) |
Tissue Specificity |
Found in several connective tissues, especially in articular cartilages. |